At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.

Research Grants 56 show all


$4.6M
2012

$21.2M
2013

$12.6M
2014

$16.2M
2015

$934.8K
2016

Patents 26,129show all

  • 8,449
    C07K - Peptides
  • 7,556
    A61K - Preparations for medical, dental, or toilet purposes
  • 2,632
    C12N - Microorganisms or enzymes
  • 2,319
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 1,205
    C07D - Heterocyclic compounds
  • 1,050
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 492
    A01K - Animal husbandry
  • 492
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 416
    C12Y - Enzymes
  • 392
    Y02A - Technologies for adaptation to climate change

Clinical Trials 1,607show all

692Phase 2314Phase 1157N/A143Phase 3119Phase 1/Phase 290Other

SEC Filings show all


64
8-K

43
10-Q

13
10-K

Contact Information

South San Francisco, CA
United States